Real-world clinical utility and impact on clinical decision-making of coronary computed tomography angiography-derived fractional flow reserve: lessons from the ADVANCE Registry
Top Cited Papers
Open Access
- 1 November 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 39 (41), 3701-3711
- https://doi.org/10.1093/eurheartj/ehy530
Abstract
Aims Non-invasive assessment of stable chest pain patients is a critical determinant of resource utilization and clinical outcomes. Increasingly coronary computed tomography angiography (CCTA) with selective CCTA-derived fractional flow reserve (FFRCT) is being used. The ADVANCE Registry, is a large prospective examination of using a CCTA and FFRCT diagnostic pathway in real-world settings, with the aim of determining the impact of this pathway on decision-making, downstream invasive coronary angiography (ICA), revascularization, and major adverse cardiovascular events (MACE). Methods and results A total of 5083 patients with symptoms concerning for coronary artery disease (CAD) and atherosclerosis on CCTA were enrolled at 38 international sites from 15 July 2015 to 20 October 2017. Demographics, symptom status, CCTA and FFRCT findings, treatment plans, and 90 days outcomes were recorded. The primary endpoint of reclassification between core lab CCTA alone and CCTA plus FFRCT-based management plans occurred in 66.9% [confidence interval (CI): 64.8-67.6] of patients. Non-obstructive coronary disease was significantly lower in ICA patients with FFRCT <= 0.80 (14.4%) compared to patients with FFRCT > 0.80 (43.8%, odds ratio 0.19, CI: 0.15-0.25, P < 0.001). In total, 72.3% of subjects undergoing ICA with FFRCT <= 0.80 were revascularized. No death/myocardial infarction (MI) occurred within 90 days in patients with FFRCT > 0.80 (n = 1529), whereas 19 (0.6%) MACE [hazard ratio (HR) 19.75, CI: 1.19-326, P = 0.0008] and 14 (0.3%) death/MI (HR 14.68, CI 0.88-246, P = 0.039) occurred in subjects with an FFRCT <= 0.80. Conclusions In a large international multicentre population, FFRCT modified treatment recommendation in two-thirds of subjects as compared to CCTA alone, was associated with less negative ICA, predicted revascularization, and identified subjects at low risk of adverse events through 90 days.Keywords
Funding Information
- HeartFlow, Inc.
- Duke Clinical Research Institute
This publication has 28 references indexed in Scilit:
- Prognostic Value of Fractional Flow ReserveJournal of the American College of Cardiology, 2014
- Fractional Flow Reserve–Guided PCI for Stable Coronary Artery DiseaseNew England Journal of Medicine, 2014
- 2014 ESC/EACTS Guidelines on myocardial revascularizationEuropean Heart Journal, 2014
- Diagnostic Performance of Noninvasive Fractional Flow Reserve Derived From Coronary Computed Tomography Angiography in Suspected Coronary Artery DiseaseJournal of the American College of Cardiology, 2014
- 2013 ESC guidelines on the management of stable coronary artery diseaseEuropean Heart Journal, 2013
- Coronary Computed Tomographic Angiography as a Gatekeeper to Invasive Diagnostic and Surgical ProceduresJournal of the American College of Cardiology, 2012
- Angiographic Versus Functional Severity of Coronary Artery Stenoses in the FAME StudyJournal of the American College of Cardiology, 2010
- Comprehensive Assessment of Coronary Artery StenosesJournal of the American College of Cardiology, 2008
- Five year trends in cardiac catheterization: A report from the registry of the society for cardiac angiography and interventionsCatheterization and Cardiovascular Diagnosis, 1996
- Cardiac catheterization 1991: A report of the registry of the society for cardiac angiography and interventions (SCA&I)Catheterization and Cardiovascular Diagnosis, 1993